MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
- Melguizo, C.
- Prados, J.
- González, B.
- Ortiz, R.
- Concha, A.
- Alvarez, P.J.
- Madeddu, R.
- Perazzoli, G.
- Oliver, J.A.
- López, R.
- Rodríguez-Serrano, F.
- Aránega, A.
Revue:
Journal of Translational Medicine
ISSN: 1479-5876
Année de publication: 2012
Volumen: 10
Número: 1
Type: Article
